“All in the past”: well, no.

Seven years ago this Editorial was published in the BMJ: Eleven years ago, all NHS Chief Executives in Scotland were asked to implement and govern this Scottish Government circular: HDL 62. This … Continue reading “All in the past”: well, no.

“Packaging up old myths”

Last week the Association of the British Pharmaceutical Industry (ABPI) held its Annual Conference: The Pharmaceutical Industry are concerned about an “affordability conundrum”: This BBC Report from November 2014: “Pharmaceutical Industry … Continue reading “Packaging up old myths”

Continuing Medical Education and its entanglement with the Pharmaceutical Industry

Yesterday I sent the e-mail (at the foot of this post) to Alex Neil, Cabinet Secretary for Health and Well-being for the Scottish Government. It should be self explanatory. My … Continue reading Continuing Medical Education and its entanglement with the Pharmaceutical Industry

Truth of an industry and the transparency of a profession

GlaxoSmithKline is fined record $3bn in US, published 3 July 2012 Reply by Dr Peter J Gordon as rapid-response to the BMJ, 10th July 2012. Truth of an industry and … Continue reading Truth of an industry and the transparency of a profession

I was not saddened

21st January 2012 Rapid-response to BMJ: I agree with Stephen Whitehead that scepticism is necessary[1]. Therefore, I was not saddened by R. Moynihan’s consideration, but rather welcomed a forthright challenge … Continue reading I was not saddened

System for disclosing hospitality should be transparent

Reply to Drug industry takes great care to be responsible healthcare partner BMJ2011;343doi: http://dx.doi.org/10.1136/bmj.d6695 (Published 26 October 2011) Published as a letter in the BMJ, October 2011: http://www.bmj.com/content/343/bmj.d7375?tab=related I have … Continue reading System for disclosing hospitality should be transparent